Big Year Ahead, page-132

For mine the Tacti Mel results of 66% ORR ,seem impressive,from what I can gather ,the result is made up of a combination of stable disease ,partial response and complete response,although a small phase 1 cohort,, the participants were not showing any response to other therapy and had very advanced disease.However it has been bandied around ,in other forums and broker analysis that the results remain perhaps only fair and the affect of EFTI remains unclear ,this is not my belief ,any thoughts.